ArticleRegenerative therapy2026
Innovative synergy of bone xenograft and quercetin in the alveolar bone socket: Histological and immunohistochemical assessment of healing.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: After an extraction, the alveolar bone may undergo shrinkage, making it more challenging to place dental implants and compromising the appearance of prosthetic rehabilitation. Studies show that alveolar bone resorption could reach 50% of the original ridge width within the first six months after extraction. Xenografts have shown promising outcomes because they are biocompatible, resemble human bone, and facilitate the growth of new bone. Xenografts, on the other hand, are mostly used as a scaffold for new bone to grow on and don't cause bone growth on their own. Because of this, their integration and remodeling often take a long time and don't always happen completely. This has led researchers to look into other biological agents that can speed up healing and bone growth. Quercetin has been shown to be bioactive, meaning it can fight inflammation and act as an antioxidant. Using a bone xenograft or another suitable carrier or scaffold with quercetin may make it more stable and concentrated at the defect site. This combination may provide the osteoconductive framework necessary for new bone deposition, as well as the osteopromotive qualities of quercetin, to accelerate the cellular and molecular processes related to healing. Methods: This study involved 64 healthy Wistar rats. The animals were randomly divided into four groups. The animals were euthanized seven to twenty-one days after extraction.Combining quercetin with a xenogenic bone graft greatly speeds up the repair of the alveolar socket. The combination encourages the production of new bone early on. Conclusion: The combination of quercetin and bone xenograft significantly improved the repair of alveolar bone sockets in Wistar rats.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.